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Abstract The artificial basic repressor SSB24 represses
transcription of a reporter construct activated by GCN4. We
show that the positively charged SSB24 and the negatively
charged acidic activator GCN4 interact in vitro and in vivo.
However, deleting the interaction domain from the GCN4
activator does not result in loss of repression by SSB24.
Similarly, transcription activated by the holoenzyme component
SRB2 is repressed, although SSB24 and SRB2 do not interact.
Repression by SSB24 therefore does not depend on the observed
protein-protein interaction between SSB24 and GCN4.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Regulation of mRNA synthesis involves a complex inter-
play of activation and repression at the transcriptional level.
Transcriptional activators are thought to recruit components
of the transcription complex to the promoter and/or stabilize
the assembled compounds. Many contacts between di¡erent
activators and general transcription factors or components of
the RNA polymerase II holoenzyme have been demonstrated
[1^5]. Disruption of the chromatin structure may also be an
important functional aspect of transcriptional activation. In
particular, several activator proteins have been shown to re-
quire histone acetyltransferase activities for activation [6^8].
Conversely, some transcriptional repressors appear to recruit
histone deacetylases [9,10]. In addition, repressors can also act
directly on the transcriptional machinery. For example, the
general corepressors Ssn6/Tup1 in yeast fail to give full repres-
sion in the absence of SRB10, a component of the RNA
polymerase II holoenzyme [11^13]. Alternatively, repressors
may impair activator function. One possibility is to interfere
with DNA binding of the activator. For example, the giant
repressor, a gap gene expressed during the blastoderm stage of
the Drosophila embryo, is proposed to prevent DNA binding
of the morphogen bicoid in the even-skipped promoter [14].
Another possibility is to interact with functional domains of
the DNA bound activator, thereby masking them from their
targets. Such a mechanism would allow a local repression
without a¡ecting neighboring segments in complex promoters
[15].
The small basic repressor SSB24 has been isolated from a
library of random fragments fused to the Gal4 DNA binding
domain (aa 1^147) in a screen for peptides repressing GCN4
activated transcription. SSB24 can repress transcription of a
reporter with Gal4 sites upstream of the GCN4 site [16]. Be-
cause SSB24 is a highly basic protein (91 amino acids, net
charge +25), we asked whether transcriptional repression
might be due to a direct interaction with the acidic activator
GCN4. Although SSB24 does indeed interact with GCN4 in
vitro and in vivo, we show in a deletion analysis that the
interacting domain in GCN4 is dispensable for repression by
SSB24. This observation suggests that SSB24 repression does
not depend on interaction with the activator but might be due
to non-speci¢c DNA binding of the positively charged factor.
2. Materials and methods
2.1. Strains and plasmids
All L-galactosidase assays were performed in strain NLY2 [16] with
the reporter SS38G4 [16] or the derivative SS38vGL, where the
GCN4 site had been replaced by a LexA site, integrated at the
Ura3 locus. LexA-activator fusions were on the Trp1 marked ARS-
CEN plasmid Y201. Y201 was derived from Y1 [17], with the Gal4-
(1^147) sequences replaced by LexA(1^202). The Gal4(1^147)-SSB24
fusion was on a 2 Wm plasmid based on the His3 marked vector
MA424 [18]. GST fusion proteins were expressed from derivatives
of pGEX-5X-1 (Pharmacia); in vitro transcription/translation reac-
tions with T7 polymerase used constructs based on pBluescript KS
(Stratagene) as templates. HA-tagged SSB24 was cloned into pET11a
(Invitrogen) and expressed in E. coli. The constructs for the split
ubiquitin assay were cloned by replacing SOD in SODCubDHFRha-
Cup314 (a gift from N. Johnsson) or by cloning into NubIpACNX.
NubIpACNX is a derivative of pADNS [19] where the 2 Wm origin
has been replaced by an ARS-CEN element and the N-terminal half
of ubiquitin is expressed under the control of the ADH1 promoter.
The assays were performed in strain JD55 [20].
2.2. L-galactosidase assays
Yeast strains transformed with the indicated plasmids were grown
in liquid culture and assayed for L-galactosidase activity as described
[21]. All values shown represent at least three independent measure-
ments.
2.3. In vitro binding assays
In vitro binding experiments to investigate protein-protein interac-
tions were done essentially as described [22]. Bacterial lysates contain-
ing approximately 50 Wg of GST fusion protein were coupled to glu-
tathione sepharose beads (Pharmacia). Beads were incubated with
20 Wl of 35S-methionine labelled protein from a TNT T7 Coupled
Reticulocyte Lysate in vitro transcription/translation reaction accord-
ing to the manufacturer’s instructions (Promega). After extensive
washing, bound proteins were released by boiling with SDS sample
bu¡er, resolved on a 15% SDS-PAGE gel and analyzed by autora-
diography. For the deletion analysis of GCN4, equal amounts of GST
fusion proteins coupled to glutathione sepharose beads were incu-
bated with 100 Wl bacterial extracts containing HA-tagged SSB24
for 1 h at 4‡C. Beads were washed ¢ve times with PBS, boiled with
SDS sample bu¡er to release bound proteins, and analyzed by West-
ern blotting with anti-HA antibody (BAbCO).
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2.4. Far Western blotting
For far Western blotting, SSB24 and SSB24C were expressed as
GST fusions in E. coli. Bacterial extracts were coupled to glutathione
sepharose beads and cleaved for 2 h at room temperature with Factor
Xa in the bu¡er recommended by the supplier (New England Biol-
abs). Aliquots of the supernatant were resolved on a 15% SDS-PAGE
gel and blotted onto nitro-cellulose. The blot was blocked in HBB
(20 mM HEPES pH 7.7, 75 mM KCl, 2.5 mM MgCl2)+5% skim milk,
incubated overnight at 4‡C in HBB+5% skim milk+1 mM DTT with
1 Wg/ml full length GCN4 protein fused to GST (puri¢ed from E. coli)
and the indicated NaCl or NP40 concentrations. Bound protein was
detected using anti-GST antibody. Washing steps were performed
with PBS+5% skim milk+0.1% Triton X-100.
2.5. Split ubiquitin assays
Yeast strain JD55 was transformed with plasmids expressing the
indicated Cub and Nub fusions. Ten ml cultures in minimal medium
were induced with 50 WM copper for 2 h to activate expression of the
Cub fusion from the CUP1 promoter, harvested and either an aliquot
was boiled with sample bu¡er and directly loaded on an SDS-PAGE
gel or extracts were prepared as described [23], but with only 80^150
Wl total volume of lysis bu¡er lacking Triton X-100. HA-tagged
DHFR from the Cub fusion was detected by Western blotting using
anti-HA antibody (BAbCO). Quantitations were performed using a
lumiimager (Boehringer).
3. Results
The small basic peptide SSB24 represses transcription when
it is tethered to the promoter by means of a fusion to Gal4(1^
147) [16]. A reporter construct containing ¢ve Gal4 sites up-
stream of a single GCN4 site is repressed approximately 5- to
6-fold by Gal4(1^147)-SSB24 compared to Gal4(1^147) alone
(Fig. 1). The C-terminal half of SSB24 (SSB24C, 45 amino
acids, net charge +15) is su⁄cient for the repression (not
shown). 3.1. Repression by SSB24 does not require SRB10
The yeast repressor K2 works by recruiting the general co-
repressors Ssn6/Tup1 to the promoter [24]. Since K2 can no
longer repress transcription in a yeast strain lacking SRB10
[11] and repression by Ssn6/Tup1 is reduced in a vsrb10 strain
[12], this protein, which is associated with the holoenzyme
[13], may be the ¢nal target of the K2 repression pathway.
While SSB24 was shown to repress transcription independ-
ently of Ssn6 [16], it might still target Tup1 or, by another
pathway, SRB10. To test this hypothesis, we investigated
SSB24 repression in an srb10 knock out strain. As shown in
Fig. 1, SSB24 is able to repress transcription independently of
SRB10.
3.2. SSB24 directly interacts with the activator GCN4
Since SSB24 is a highly basic protein, we asked whether
transcriptional repression might be due to a direct interaction
with the acidic activator GCN4, which may potentially mask
the activator’s function. In an in vitro binding assay, the two
proteins do indeed interact (Fig. 2A). In vitro translated
GCN4(1^220) binds to GST-SSB24 and GST-SSB24C, but
not to the GST control. SSB24C is a derivative of SSB24
consisting of only the C-terminal half. As a Gal4(1^147) fu-
sion, SSB24C is su⁄cient for transcriptional repression (not
shown). In the in vitro binding assay, a GCN4 derivative
lacking the DNA binding domain (aa 1^220) was used to
avoid possible DNA bridging in the binding reaction, since
DNA was present in the in vitro translated protein prepara-
tion. In order to demonstrate the interaction with an inde-
pendent method, a far Western blot was performed (Fig.
2B). This method uses puri¢ed proteins, showing that the
Fig. 1. Repression by SSB24 in wt and srb10 knockout strains. L-
galactosidase activity was assayed from strains with an integrated
reporter containing ¢ve Gal4 sites upstream of a single GCN4 site
(depicted at the top). Gal4(1^147)-SSB24 (black columns) or
Gal4(1^147) alone (grey columns) were expressed from a plasmid.
Results are shown for wt (left) and srb10 knockout (right) genetic
backgrounds. For better comparison, values for the Gal4(1^147)
were set to 1.
Fig. 2. SSB24 and GCN4 interact in vitro. A: Interaction of SSB24
and GCN4(1^220) in an in vitro binding assay. In vitro translated
35S labelled GCN4(1^220) was incubated with GST fusion proteins
coupled to glutathione sepharose beads. Bound protein was resolved
on an SDS-PAGE gel and analyzed by autoradiography. GST fu-
sion proteins are indicated at the top. GCN4(1^220) (24 kDa) runs
with an apparent molecular weight of approximately 50 kDa in
SDS-PAGE gels. B: Interaction of SSB24 and GCN4 in a far West-
ern blot. SSB24 (lanes 1, 3, 5) and SSB24C (lanes 2, 4, 6) were re-
solved on an SDS-PAGE gel and blotted onto nitro-cellulose. The
blot was incubated with puri¢ed full length GCN4 protein fused to
GST at 1 mg/ml. The binding bu¡er contained 75 mM KCl plus
the NaCl concentrations indicated at the top. Bound protein was
detected using an anti-GST antibody. The SSB24 preparation con-
tained degradation products which interact with GCN4, too.
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interaction must be direct. As seen in the in vitro binding
assay (Fig. 2A), the C-terminal half of SSB24 (SSB24C) is
also su⁄cient for interaction with GCN4 in the far Western
blot (compare lanes 1 and 2). When the salt concentration in
the binding bu¡er was enhanced to 400 mM NaCl, the bind-
ing became signi¢cantly weaker (Fig. 2B). Conversely, includ-
ing 0.5% or 1% of the non-ionic detergent NP40 in the bind-
ing bu¡er enhanced the association between SSB24 and
GCN4 to some extent (not shown). This observation indicates
that the interaction is of an ionic nature, as would be expected
for two highly charged proteins.
To investigate whether the SSB24 and GCN4 proteins
could also interact in vivo, we used the split ubiquitin assay
[25]. Unlike the 2-hybrid assay, this method is independent of
a transcriptional readout and can therefore also be used to
analyze transcription factors. The two proteins tested are
fused to the N-terminal and the C-terminal half of ubiquitin,
respectively. One of the fusions carries as a reporter an HA-
tagged protein that can be detected in a Western blot. If the
two tested proteins interact, the reassociated halves of the
ubiquitin moiety are recognized by a ubiquitin speci¢c pro-
tease and the reporter is cleaved C-terminal of the ubiquitin
(Fig. 3A). The cleavage e⁄ciency can be monitored by West-
ern blotting, because the full length and cleaved reporter
yields bands of distinct size. As shown in Fig. 3B, expression
of a fusion of SSB24C and the N-terminal half of ubiquitin
(Nub) signi¢cantly enhances cleavage e⁄ciency with a report-
er fused to GCN4(1^220) and the C-terminal half of ubiquitin
(Cub). The same result is seen with an Nub fusion of SSB24
(not shown). When we controlled the expression level of Nub
and Nub-SSB24C in a Western blot, we found that Nub alone
is expressed at least 10-fold more than the Nub-SSB24C fu-
sion (Fig. 3C). The expression of Nub alone is already su⁄-
cient to give substantial cleavage. However, relative cleavage
e⁄ciency was always markedly increased in the presence of
the Nub-SSB24C, despite the much lower expression level of
the fusion protein.
3.3. Deletion analysis of GCN4
Next, we sought to determine whether SSB24 interacts with
the acidic activation domain of GCN4, located between ami-
no acids 87 and 154 [26], as would be suggested by the ¢nding
that the interaction is ionic in nature. Surprisingly, an in vitro
binding assay with di¡erent deletion derivatives of GCN4
(shown schematically in Fig. 4A) revealed that the interaction
domain resides C-terminal of the activation domain instead.
This domain, aa 153^220, is both necessary and su⁄cient for
the in vitro interaction with SSB24 (Fig. 4B, compare lanes
4 and 7).
In an approach aiming to elucidate the relevance of the
de¢ned interaction domain for in vivo repression, we used
the di¡erent GCN4 constructs in repression assays. To avoid
interference by endogenous GCN4, a LexA fusion was used in
combination with a reporter containing ¢ve Gal4 sites up-
stream of a single LexA site (Fig. 4C). In contrast to wild-
type GCN4, whose DNA binding domain is at the C-termi-
nus, the heterologous DNA binding domain was fused to the
N-terminus in these constructs. This may explain the weak
activation potential of the constructs containing the region
C-terminal of the activation domain (aa 153^220). The di¡er-
ent GCN4 constructs show a high variation in their ability to
activate transcription (2.2 L-galactosidase units for GCN4 87^
Fig. 3. SSB24C and GCN4 interact in vivo. A: Schematic represen-
tation of the split ubiquitin assay: When a protein is marked with
ubiquitin, ubiquitin speci¢c protease will cleave C-terminal of the
ubiquitin moiety. If only the C-terminal half of ubiquitin (Cub) is
fused to the protein, there will be hardly any cleavage (lane 1).
When the N-terminal half (Nub) of ubiquitin is coexpressed, some
molecules will reassociate, leading to a slightly enhanced cleavage
rate (lane 2). If, however, the Nub moiety is fused to a protein that
interacts with a protein fused to the Cub reporter construct, this in-
teraction will bring the two halves of ubiquitin together, resulting in
more prominent cleavage. B: Western blot showing interaction be-
tween SSB24C and GCN4(1^220). Yeast cells expressing GCN4(1^
220)-Cub-DHFR (lane 1) or GCN4(1^220)-Cub-DHFR in combina-
tion with Nub alone (lane 2) or Nub-SSB24C (lane 3) were boiled
with SDS sample bu¡er and loaded on a gel for Western blotting
with anti-HA antibody. The positions of the full length Cub fusion
and the cleaved HA-DHFR product are marked. C: Western blot
with anti-HA antibody showing the expression level of Nub-SSB24C
and Nub in strain JD55.
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220 versus 330 units for GCN4 1^152, Fig. 4C). However, all
constructs are repressed by SSB24. Therefore, interaction with
the activator does not seem to be important for repression by
SSB24, because a GCN4 derivative lacking the SSB24 inter-
action domain (GCN4 1^152) is still repressed e⁄ciently.
3.4. SSB24 also represses transcription activated by SRB2
While we could not detect interaction between SSB24 and
the activation domain of GCN4 in our in vitro assay, it
seemed possible that a relevant weak interaction exists when
the two proteins are placed in close proximity by binding to
the promoter region together. Indeed, we observed a weak
interaction between SSB24C and the activation domain of
GCN4 alone (aa 87^152) in the split ubiquitin in vivo assay
(data not shown). In order to test if such a weak interaction
might be responsible for the repression by SSB24, we sought
to repeat the repression experiments using an activator com-
pletely de¢cient in SSB24 interaction. Typical yeast activator
proteins have an acidic activation domain and may thus, like
GCN4, interact weakly with the positively charged SSB24. We
therefore used a LexA fusion of SRB2 which, like nearly all
holoenzyme components tested, enhances transcription when
tethered to a promoter, presumably by recruiting the holoen-
zyme complex [27^29]. As shown in Fig. 5A, SRB2 does not
interact with SSB24 in the split ubiquitin in vivo assay. None-
Fig. 5. SSB24 represses transcription activated by SRB2. A: SSB24
does not interact with SRB2 in the split ubiquitin assay. Extracts
were prepared from cells expressing SRB2-Cub-DHFR in combina-
tion with Nub alone (left) or Nub-SSB24 (right). Aliquots were
loaded on a gel for Western blotting with an anti-HA antibody.
The position of the full length Cub fusion and the cleaved product
is indicated. The percentage of cleavage in the presence of Nub-
SSB24 is not enhanced compared to Nub alone (19 and 17%
cleaved, respectively, as quantitated with a lumiimager (Boeh-
ringer)). B: Transcription activated by LexA-SRB2 is e⁄ciently re-
pressed by SSB24. A yeast strain with the integrated reporter indi-
cated at the top was transformed with LexA fusions of GCN4-
(1^220) or SRB2 as indicated and the Gal4(1^147) alone (grey col-
umns) or fused to SSB24 (black columns), and L-galactosidase activ-
ity was determined. Transcription activated by LexA-SRB2 was at
least as e⁄ciently repressed by SSB24 as the Lex-GCN4(1^220) con-
trol.
Fig. 4. Deletion analysis of GCN4. A: Schematic representation of
the GCN4 derivatives used. B: In vitro interaction of SSB24 with
GCN4 requires the domain C-terminal of the activation domain.
Bacterial lysates containing HA-tagged SSB24 (lanes 3^7) or control
lysate (lane 8) were incubated with GST fusion proteins coupled to
glutathione sepharose beads. Bound protein was detected by West-
ern blotting using anti-HA antibody. Lanes 1 and 2 show 2% input
of the HA-SSB24 and control extracts, respectively. The GST fu-
sions used are as follows: Lane 3, GST; lane 4, GST-GCN4-
(1^152); lane 5, GST-GCN4(87^152); lane 6, GST-GCN4(87^220);
lanes 7, 8, GST-GCN4(153^220). C: Repression of di¡erent GCN4
derivatives by SSB24. L-galactosidase activity was assayed from a
strain with an integrated reporter containing ¢ve Gal4 sites up-
stream of a single LexA site (depicted at the top). Gal4(1^147)-
SSB24 (black columns) or Gal4(1^147) alone (grey columns) and
the indicated LexA-GCN4 fusions (compare Fig. 5A) were expressed
from plasmids.
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theless transcription activated by a LexA-SRB2 fusion is re-
pressed by SSB24 (Fig. 5B). We conclude that SSB24 repres-
sion is not triggered by interaction with the activator. An
alternative mechanism would be non-speci¢c binding to the
negatively charged DNA backbone, which may interfere with
the binding and/or function of (an)other factor(s).
4. Discussion
Protein-protein interactions play a key role in transcription-
al regulation. Activators interact with their target proteins to
open up chromatin or to transmit signals to the transcription-
al machinery. However, interaction with another protein can
also impair a transcriptional activator’s ability to enhance m-
RNA synthesis. For example, such a scenario has been re-
ported for pairs of activators which can, when bound together
to speci¢c promoters, cancel each other out. In particular, the
glucocorticoid receptor can impair AP-1 as well as NFkB
activation function in certain cases [30,31].
A mechanism involving direct interaction with the activator
protein has also been proposed for the Drosophila repressor
snail. This was based on the observation that e⁄cient repres-
sion by snail requires the binding sites to be located within
100 bp of the activator sites [15]. Snail does indeed interact
with dorsal, one of the activators of the rhomboid enhancer
which is repressed by snail, in vitro (A.W. and N.L., unpub-
lished observation). However, snail can also repress transcrip-
tion from a promoter proximal position independent of acti-
vator sites [32]. It has recently been established that snail can
interact with the corepressor dCtBP [33].
In a similar way as snail, the arti¢cial repressor SSB24 had
also been shown to lose its repression potential when the bind-
ing sites were removed far away from the activator sites [16].
Its high positive charge suggested that it might interact with
the negatively charged activator GCN4, which is repressed by
SSB24. We show that SSB24 and GCN4 do interact in vitro
and in vivo and that the interaction is ionic in nature. How-
ever, a deletion analysis of GCN4 revealed unexpectedly that
the interacting domain is not the highly charged activation
domain but the adjacent domain towards the C-terminus.
Consequently, it was possible to construct a GCN4 derivative
lacking the interaction domain but retaining the ability to
activate transcription. Because this activator construct was
still repressed e⁄ciently by SSB24, the interaction between
SSB24 and GCN4 cannot be the mechanistic background of
repression by SSB24. Similarly, transcription activated by a
LexA fusion of SRB2, a holoenzyme component unable to
interact with SSB24, was repressed, which suggests that
SSB24 repression is not speci¢c to acidic activators.
While SSB24 interaction with the activator was shown not
to be relevant for its repression function, it does not target
either the general corepressors Ssn6/Tup1 or the holoenzyme
component SRB10 ([16] and this study). We cannot rule out
the possibility that SSB24 makes contact to other proteins
which may in turn a¡ect transcriptional activity. However,
SSB24 may act by a di¡erent mechanism, namely by interact-
ing with the negatively charged phosphate backbone of pro-
moter DNA. Such a mechanism would explain why a large
spacing between activator and repressor sites results in loss of
repression. Interestingly, a lac-repressor fusion of the basic
peptide LysAla, which had been designed to mimic SSB24
[16], resulted in enhanced repression by the dimeric form of
lac repressor [34]. This was explained by the ability of the
mutant lac repressor to make non-speci¢c contacts to DNA
via the basic tail. SSB24 may therefore simply block binding
of the activator or other factors to the promoter region by
binding and distorting the DNA helix.
While we could show interaction between GCN4 and
SSB24 with a variety of in vitro and in vivo methods, our
transcription assays indicate that this interaction is irrelevant
for the observed function of SSB24. We conclude that dem-
onstration of protein-protein interactions has to be treated
with care until a functional assay for the in vivo situation is
available.
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